In a study of patients who were discharged from a receiving facility without undergoing a procedure, the investigators conclude that about a third of transfers might be avoided.
Transfer of trauma patients from one emergency department (ED) to another is costly, inconvenient, and subjects the patient to the risks of motor vehicle transport. Investigators analyzed government data from six states, including all visits with an ED-to-ED transfer and a diagnostic code indicating injury.
They identified almost 50,000 visits with transfer to another ED. Fewer than half (22,000) of transferred patients were transferred to a higher level of care (i.e., a trauma center). Of transfer patients, 36% were discharged from the receiving facility without being admitted or undergoing any therapeutic procedure (including laceration repair; wound care; fracture reduction, casting, or splinting; intubation, mechanical ventilation, or ce…
Reviewing Author
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals